Task: Answer the multiple-choice question.
Query: Which drug exhibits a -28.497% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1nc2c3ccccc3nc(NNC(=O)CCC(=O)N3CCN(c4ccccc4)CC3)n2n1
b.) CC(CC(=O)OCC(=O)NCc1ccc(Cl)cc1)c1ccccc1
Answer: a. Cc1nc2c3ccccc3nc(NNC(=O)CCC(=O)N3CCN(c4ccccc4)CC3)n2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2c3ccccc3nc(NNC(=O)CCC(=O)N3CCN(c4ccccc4)CC3)n2n1
Cc1nc2c3ccccc3nc(NNC(=O)CCC(=O)N3CCN(c4ccccc4)CC3)n2n1
N'-(2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-4-oxo-4-(4-phenylpiperazin-1-yl)butanehydrazide